• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

线粒体移植通过增强抗肿瘤免疫力使化疗更有效地抑制肿瘤发展。

Mitochondrial transplantation sensitizes chemotherapy to inhibit tumor development by enhancing anti-tumor immunity.

作者信息

Lin Shumeng, Yuan Liuliu, Chen Xiao, Chen Shiyin, Wei Mengling, Hao Bingjie, Zheng Tiansheng, Fan Lihong

机构信息

Institute of Energy Metabolism and Health, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.

Department of Respiratory Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.

出版信息

Cancer Biol Med. 2025 Jun 19;22(6):648-71. doi: 10.20892/j.issn.2095-3941.2024.0596.

DOI:10.20892/j.issn.2095-3941.2024.0596
PMID:40538008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12240198/
Abstract

OBJECTIVE

Lung cancer is the leading cause of cancer-related deaths worldwide. Chemotherapy is associated with side effects, such as damage to myeloid cells and a reduction in the number of immune cells in patients. In addition, tumor cells hijack the mitochondria of immune cells through tunnel nanotubes, thereby weakening immune ability.

METHODS

In this study the effects of direct mitochondria transplantation on cancer cell proliferation and chemotherapeutic sensitivity were determined, as well as anti-tumor immunity in and lung cancer models.

RESULTS

A combination of mitochondrial transplantation and cisplatin chemotherapy was shown for the first time to significantly improve immune infiltration of advanced non-small cell lung cancer (NSCLC) and overcome the shortcomings of cisplatin chemotherapy, including damage to myeloid cells and a reduction in the number of immune cells.

CONCLUSIONS

The findings of the current study provide valuable recommendations for enhancing immune infiltration and augmenting anti-tumor efficacy during chemotherapy in advanced NSCLC. In addition, the findings support "mitochondrial transfer" as a novel paradigm in tumor treatment.

摘要

目的

肺癌是全球癌症相关死亡的主要原因。化疗会产生副作用，如对骨髓细胞的损伤以及患者体内免疫细胞数量的减少。此外，肿瘤细胞通过隧道纳米管劫持免疫细胞的线粒体，从而削弱免疫能力。

方法

在本研究中，测定了直接线粒体移植对癌细胞增殖和化疗敏感性的影响，以及在肺癌模型中的抗肿瘤免疫作用。

结果

首次表明线粒体移植与顺铂化疗联合使用可显著改善晚期非小细胞肺癌（NSCLC）的免疫浸润，并克服顺铂化疗的缺点，包括对骨髓细胞的损伤和免疫细胞数量的减少。

结论

本研究结果为增强晚期NSCLC化疗期间的免疫浸润和提高抗肿瘤疗效提供了有价值的建议。此外，这些结果支持“线粒体转移”作为肿瘤治疗的一种新范式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/2ada0111093a/cbm-22-06-648-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/e2e1bebb82b2/cbm-22-06-648-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/a03790d8be70/cbm-22-06-648-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/1242a5b179fb/cbm-22-06-648-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/a8dac372754b/cbm-22-06-648-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/aa4cb0e950f0/cbm-22-06-648-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/678228fec296/cbm-22-06-648-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/af87224b4b4b/cbm-22-06-648-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/428424dc06e9/cbm-22-06-648-g008a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/2ada0111093a/cbm-22-06-648-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/e2e1bebb82b2/cbm-22-06-648-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/a03790d8be70/cbm-22-06-648-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/1242a5b179fb/cbm-22-06-648-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/a8dac372754b/cbm-22-06-648-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/aa4cb0e950f0/cbm-22-06-648-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/678228fec296/cbm-22-06-648-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/af87224b4b4b/cbm-22-06-648-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/428424dc06e9/cbm-22-06-648-g008a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a6a/12240198/2ada0111093a/cbm-22-06-648-g009.jpg

相似文献

1
Mitochondrial transplantation sensitizes chemotherapy to inhibit tumor development by enhancing anti-tumor immunity.线粒体移植通过增强抗肿瘤免疫力使化疗更有效地抑制肿瘤发展。
Cancer Biol Med. 2025 Jun 19;22(6):648-71. doi: 10.20892/j.issn.2095-3941.2024.0596.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Midkine Promotes Tumor Growth and Attenuates the Effect of Cisplatin in Small Cell Lung Cancer.中期因子促进小细胞肺癌的肿瘤生长并减弱顺铂的作用。
Cancer Med. 2025 Jul;14(13):e71034. doi: 10.1002/cam4.71034.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Systemic treatment patterns and adherence to guidelines in Japanese patients with metastatic non-small cell lung cancer.日本转移性非小细胞肺癌患者的系统治疗模式及对指南的依从性
Future Oncol. 2025 Apr;21(9):1101-1111. doi: 10.1080/14796694.2025.2470611. Epub 2025 Feb 28.
6
Correlation of senescence-related gene FEN1 on neuroblastoma progression and cisplatin chemotherapy sensitivity.衰老相关基因FEN1与神经母细胞瘤进展及顺铂化疗敏感性的相关性
Oncol Res. 2025 Jun 26;33(7):1695-1708. doi: 10.32604/or.2025.060021. eCollection 2025.
7
Immune checkpoint inhibitors plus platinum-based chemotherapy compared to platinum-based chemotherapy with or without bevacizumab for first-line treatment of older people with advanced non-small cell lung cancer.免疫检查点抑制剂联合铂类化疗对比铂类化疗联合或不联合贝伐珠单抗用于治疗老年人晚期非小细胞肺癌的一线治疗。
Cochrane Database Syst Rev. 2024 Aug 13;8(8):CD015495. doi: 10.1002/14651858.CD015495.
8
Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review.厄洛替尼或吉非替尼治疗铂类预处理复发的非小细胞肺癌和卵巢癌：系统评价。
Drug Resist Updat. 2011 Jun;14(3):177-90. doi: 10.1016/j.drup.2011.02.004. Epub 2011 Mar 24.
9
A systematic overview of chemotherapy effects in non-small cell lung cancer.非小细胞肺癌化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):327-39. doi: 10.1080/02841860151116402.
10
Pomalidomide sensitizes lung cancer cells to TRAIL/CDDP-induced apoptosis via directly targeting electron transfer flavoprotein alpha subunit.泊马度胺通过直接靶向电子传递黄素蛋白α亚基使肺癌细胞对TRAIL/顺铂诱导的凋亡敏感。
Bioorg Chem. 2024 Dec;153:107815. doi: 10.1016/j.bioorg.2024.107815. Epub 2024 Sep 11.

本文引用的文献

1
Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy.细胞间纳米管介导的线粒体转移增强 T 细胞代谢适应性和抗肿瘤疗效。
Cell. 2024 Nov 14;187(23):6614-6630.e21. doi: 10.1016/j.cell.2024.08.029. Epub 2024 Sep 13.
2
Mitochondrial dysfunction: mechanisms and advances in therapy.线粒体功能障碍：机制与治疗进展。
Signal Transduct Target Ther. 2024 May 15;9(1):124. doi: 10.1038/s41392-024-01839-8.
3
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
2022 年全球癌症统计数据：全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
4
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.癌症生物标志物：个性化治疗的新兴趋势和临床意义。
Cell. 2024 Mar 28;187(7):1617-1635. doi: 10.1016/j.cell.2024.02.041.
5
Effective γδ T-cell clinical therapies: current limitations and future perspectives for cancer immunotherapy.有效的γδ T细胞临床疗法：癌症免疫疗法的当前局限性与未来展望
Clin Transl Immunology. 2024 Feb 19;13(2):e1492. doi: 10.1002/cti2.1492. eCollection 2024.
6
The role of ROS in tumor infiltrating immune cells and cancer immunotherapy.活性氧簇在肿瘤浸润免疫细胞和癌症免疫治疗中的作用。
Metabolism. 2024 Feb;151:155747. doi: 10.1016/j.metabol.2023.155747. Epub 2023 Nov 30.
7
Application of radiomics in diagnosis and treatment of lung cancer.放射组学在肺癌诊断与治疗中的应用。
Front Pharmacol. 2023 Nov 1;14:1295511. doi: 10.3389/fphar.2023.1295511. eCollection 2023.
8
Hijacking homeostasis: Regulation of the tumor microenvironment by apoptosis.劫持内稳态：细胞凋亡对肿瘤微环境的调控。
Immunol Rev. 2023 Oct;319(1):100-127. doi: 10.1111/imr.13259. Epub 2023 Aug 8.
9
Dissecting the alternation landscape of mitochondrial metabolism-related genes in lung adenocarcinoma and their latent mechanisms.解析肺腺癌中线粒体代谢相关基因的交替景观及其潜在机制。
Aging (Albany NY). 2023 Jun 15;15(12):5482-5496. doi: 10.18632/aging.204803.
10
Mechano-modulation of T cells for cancer immunotherapy.用于癌症免疫治疗的T细胞机械调节
Biomaterials. 2023 Jun;297:122101. doi: 10.1016/j.biomaterials.2023.122101. Epub 2023 Apr 1.